Pasithea Therapeutics Corp. (NASDAQ:KTTA – Get Free Report) fell 1.8% on Tuesday . The company traded as low as $5.60 and last traded at $5.60. 463 shares were traded during trading, a decline of 94% from the average session volume of 7,761 shares. The stock had previously closed at $5.71. Pasithea Therapeutics Trading Down 1.6 […]
Pasithea Therapeutics Announces The First Cohort Has Completed The Initial Dosing In Its Phase 1 Trial Evaluating PAS-004 In RAS, NF1 And RAF Mutated ... menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Pasithea Therapeutics (NASDAQ:KTTA) Trading Down 0.4% theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Pasithea Therapeutics Corp. (NASDAQ:KTTA – Get Free Report)’s stock price dropped 2.1% on Wednesday . The stock traded as low as $7.00 and last traded at $7.15. Approximately 1,502 shares traded hands during trading, a decline of 87% from the average daily volume of 11,483 shares. The stock had previously closed at $7.30. Pasithea Therapeutics […]
Pasithea Therapeutics Corp. (NASDAQ:KTTA – Get Free Report) was the target of a large growth in short interest in January. As of January 15th, there was short interest totalling 13,500 shares, a growth of 29.8% from the December 31st total of 10,400 shares. Approximately 0.1% of the shares of the stock are short sold. Based […]